View in EDS

Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents.

Saved in:
Bibliographic Details
Title: Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents.
Authors: Spadafora, Luigi1,2 (AUTHOR) luigispadafora167@gmail.com, Russo, Federico3,4 (AUTHOR), Bukowska-Olech, Ewelina5 (AUTHOR), Panichella, Giorgia6 (AUTHOR), Garofalo, Manuel6 (AUTHOR), Cacciatore, Stefano7,8 (AUTHOR), Sabouret, Pierre9 (AUTHOR), Sarto, Gianmarco10 (AUTHOR), Simeone, Beatrice10 (AUTHOR), Rocco, Erica10 (AUTHOR), Lauretti, Attilio2 (AUTHOR), Versaci, Francesco2 (AUTHOR), Zoccai, Giuseppe Biondi1,11 (AUTHOR), Colaiori, Iginio2 (AUTHOR), Valenti, Valentina1,11 (AUTHOR), Sciarretta, Sebastiano1,12 (AUTHOR), Bernardi, Marco1,2 (AUTHOR)
Source: American Journal of Cardiovascular Drugs. Jan2026, Vol. 26 Issue 1, p21-34. 14p.
Database: Academic Search Ultimate
Description
ISSN:11753277
DOI:10.1007/s40256-025-00757-6